FDA Advisory Committee to Consider Tofersen…
Podcast |
Connecting ALS
Publisher |
ALS Association
Media Type |
audio
Categories Via RSS |
Health & Fitness
Society & Culture
Publication Date |
Mar 09, 2023
Episode Duration |
00:27:23

This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.

 

For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review